News Update: Eli Lilly Stops Development of Alzheimer Drug Following Disappointing Results

News Update: Eli Lilly Stops Development Of Alzheimer Drug Following Disappointing Results – Eli Lilly (NYSE:LLY) has stopped developing its possible treatment for Alzheimer’s disease. The decision comes at a time when the firm has been looking for n…